Carson C. Y. Yip

Carson C. Y. Yip

Auto-generated profile, based on publicly available information

Carson C. Y. Yip

Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong SAR, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Journal of Clinical Rheumatology and Immunology
Verified
Journal Article
Open access
CYCarson C. Y. Yip
Carson C. Y. Yip
ICIsaac Tsz Ho Cheng
Isaac Tsz Ho Cheng
SLSze-Lok Lau
Sze-Lok Lau
LTLai-Shan Tam
Lai-Shan Tam
HSHo So
Ho So
Background: IgG4-related disease (IgG4-RD) is a systemic fibro-inflammatory disease that can affect almost any organ throughout its course. However, its longitudinal outcomes in the Southern Chinese population remain poorly characterized. Methods: We conducted a retrospective cohort study of consecutive IgG4-RD patients from November 2018 to October 2023 at a tertiary rheumatology unit in Hong Kong. Clinical characteristics, treatment patterns and outcomes, as well as factors associated with deep organ involvement were evaluated. Results: A total of 43 IgG4-RD patients (63% male, median age at diagnosis [ ] 68) with a median follow-up duration of 3.7 years were included. Multiorgan involvement (77%) and head-and-neck-limited disease (65%) were common. Multiorgan involvement was associated with a longer diagnostic delay ([ ][ ]0.339, [ ][ ]0.032). Deep organ involvement (37%) was associated with higher median baseline neutrophil counts (5.0 vs. 4.0 × 10 9 /L, [ ][ ]0.049) and a greater number of affected organs (3 vs. 2, [ ][ ] 0.003), requiring higher induction prednisolone doses and more frequent use of steroid-sparing agents. Glucocorticoid therapy led to a clinical response in all treated patients (72%), but relapse occurred in 29% of them after a median follow-up of 61 weeks. Conclusion: In this Southern Chinese cohort, IgG4-RD frequently involved deep and multiple organs. Early recognition may help prevent the development of multisystem disease. Further studies are warranted to identify optimal management strategies for IgG4-RD in this population.